| abstract |
The invention relates to 9-chloro-prostaglandin derivatives of formula I ##STR1## in which X means oxygen or CH 2 , n R 1 means hydrogen or straight-chain or branched alkyl with 1-6 C atoms and n A means trans-CH═CH-- or --CH 2 --CH 2 --, n as well as their salts with physiologically compatible bases, if R 1 represents hydrogen, and their clathrates with α-, β- or γ-cyclodextrin, process for their production and their pharmaceutical use. |